Twice-daily chemoradiotherapy must still be the choice for patients with limited-stage small-cell lung cancer

J Thorac Dis. 2017 Sep;9(9):2843-2846. doi: 10.21037/jtd.2017.08.113.

Authors

Fernando Franco¹, David Pérez-Callejo¹, Mariano Provencio¹

Affiliation

¹ Medical Oncology Department, Hospital Universitario Puerta de Hierro Majadahonda, Madrid, Spain.

No abstract available

Publication types

Editorial
Comment